Pharma Focus America

Building a unified 𝐝𝐞𝐬𝐢𝐠𝐧-𝐦𝐚𝐤𝐞-𝐭𝐞𝐬𝐭-𝐝𝐞𝐜𝐢𝐝𝐞 approach is becoming critical as drug discovery grows more complex. From small molecules to ADCs and cell therapies, fragmented data and siloed teams can slow decision-making and innovation. A unified DMTA framework, supported by integrated informatics, helps research teams connect data, streamline workflows, and turn insights into action—faster and with confidence. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐏𝐃𝐅 & 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐆𝐮𝐢𝐝𝐞 to see how integrated informatics supports scalable, compliant, and collaborative scientific research. Download now: https://lnkd.in/dmszidys #DrugDiscovery #DMTA #IntegratedInformatics #LifeSciences #PharmaInnovation #RAndD #ScientificData #Biopharma #DigitalTransformation

𝐁𝟐𝐁 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐒𝐀 𝐢𝐬 𝐜𝐡𝐚𝐧𝐠𝐢𝐧𝐠—𝐚𝐧𝐝 𝐟𝐚𝐬𝐭. In a market shaped by strict compliance, long sales cycles, and digitally mature buyers, pharma marketers must align credibility, compliance, and commercial impact to drive real ROI. 𝐊𝐞𝐲 𝐭𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐚𝐫𝐭𝐢𝐜𝐥𝐞: • Proven B2B pharma marketing strategies for the US market • High-impact channels driving qualified lead generation • Compliance-first marketing as a competitive advantage • Emerging trends shaping pharma marketing ROI 📈 Designed for pharma leaders, marketers, and business strategists navigating complex buying journeys. 👉 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐡𝐞𝐫𝐞: https://lnkd.in/dZacwm9K #PharmaMarketing #B2BPharma #USPharma #LifeSciencesMarketing #HealthcareMarketing #PharmaCompliance #PharmaTrends #DigitalPharma #PharmaStrategy #PharmaROI

AI is changing how drugs are designed—but strong science still matters. Modern drug discovery now generates massive datasets across genomics, screening, imaging, and patient data. The real challenge lies in interpretation. AI is stepping in to reveal hidden patterns, predict molecular behavior, and accelerate smarter decisions—while raising critical questions around trust, transparency, and human-AI collaboration. Join the 𝐑𝐞𝐯𝐯𝐢𝐭𝐲 𝐨𝐧-𝐝𝐞𝐦𝐚𝐧𝐝 𝐰𝐞𝐛𝐢𝐧𝐚𝐫 to see how advanced AI, machine learning, and integrated informatics platforms are strengthening antibody discovery and developability assessment. 🔹 AI in biological signal interpretation 🔹 Antibody developability dashboards 🔹 ImmuneBuilder & deep-learning–based structure prediction 📄 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐏𝐃𝐅 ▶️ 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐭𝐨 𝐰𝐚𝐭𝐜𝐡 𝐭𝐡𝐞 𝐨𝐧-𝐝𝐞𝐦𝐚𝐧𝐝 𝐰𝐞𝐛𝐢𝐧𝐚𝐫 https://lnkd.in/dgU3xNYT #DrugDiscovery #ArtificialIntelligence #Biopharma #AntibodyEngineering #ComputationalBiology #MachineLearning #PharmaInnovation #LifeSciences #Bioinformatics

Senior laboratory and R&D leaders across the U.S. are coming together this April in Philadelphia for a highly curated, invite-only exchange focused on 𝐫𝐞𝐚𝐥-𝐰𝐨𝐫𝐥𝐝 𝐥𝐚𝐛 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧. https://lnkd.in/d9uJRsjs SmartLab Exchange USA 2026 brings senior leaders from Pfizer, Novo Nordisk, Takeda, Johnson & Johnson, Estée Lauder Companies, and more into a closed-door environment designed for peer-to-peer learning, practical case studies, and honest conversations on what’s actually working in modern laboratories. 📍 Philadelphia, USA 📅 April 20–21, 2026 If you’re responsible for lab digitalization, automation, data integrity, or operational excellence, this forum is built for you. 👉 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐲𝐨𝐮𝐫 𝐢𝐧𝐯𝐢𝐭𝐚𝐭𝐢𝐨𝐧 𝐭𝐨𝐝𝐚𝐲: https://lnkd.in/d9uJRsjs #SmartLab #PharmaLeadership #LabTransformation #DigitalLabs #PharmaRND #BiotechInnovation #LaboratoryAutomation #LifeSciences #PharmaEvents #DataIntegrity #OperationalExcellence

Laboratory capsule filters support efficient, contamination-free filtration for 𝐜𝐞𝐥𝐥 𝐜𝐮𝐥𝐭𝐮𝐫𝐞 and 𝐥𝐢𝐟𝐞 𝐬𝐜𝐢𝐞𝐧𝐜𝐞 𝐰𝐨𝐫𝐤𝐟𝐥𝐨𝐰𝐬. This brochure highlights single-use capsule filters designed for media and buffer prep, clarification, cell harvest, and sterile filtration—offering high flow rates, low protein binding, and scalable performance from lab to larger volumes. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐛𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dCS8CewR #LaboratoryFiltration #CellCulture #Bioprocessing #LifeSciences #SterileFiltration #Biotech

Artificial intelligence is redefining 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐨𝐯𝐢𝐠𝐢𝐥𝐚𝐧𝐜𝐞 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧—from faster case intake using OCR and NLP to AI-driven signal detection, causality assessment, and predictive safety analytics. As global safety data volumes grow, AI/ML technologies are helping pharmacovigilance teams improve 𝐚𝐜𝐜𝐮𝐫𝐚𝐜𝐲, 𝐜𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞, 𝐜𝐨𝐧𝐬𝐢𝐬𝐭𝐞𝐧𝐜𝐲, 𝐚𝐧𝐝 𝐭𝐮𝐫𝐧𝐚𝐫𝐨𝐮𝐧𝐝 𝐭𝐢𝐦𝐞𝐬, while shifting focus from manual processing to proactive risk management and patient safety. Pharma organizations that adopt AI-enabled pharmacovigilance today are better positioned to meet regulatory expectations and scale efficiently across the product lifecycle. 👉 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐨𝐧 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐚𝐧𝐝 𝐬𝐭𝐚𝐲 𝐚𝐡𝐞𝐚𝐝 𝐢𝐧 𝐀𝐈-𝐩𝐨𝐰𝐞𝐫𝐞𝐝 𝐝𝐫𝐮𝐠 𝐬𝐚𝐟𝐞𝐭𝐲: https://lnkd.in/giq9QhCj #Pharmacovigilance #ArtificialIntelligence #DrugSafety #MachineLearning #ClinicalResearch #LifeSciences #RegulatoryAffairs #DigitalHealth #PharmaInnovation #PatientSafety #HealthcareTechnology #AIinHealthcare

𝐏𝐡𝐚𝐫𝐦𝐚 𝐬𝐮𝐩𝐩𝐥𝐲 𝐜𝐡𝐚𝐢𝐧𝐬 𝐢𝐧 𝟐𝟎𝟐𝟔 𝐝𝐞𝐦𝐚𝐧𝐝 𝐦𝐨𝐫𝐞 𝐭𝐡𝐚𝐧 𝐞𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲—𝐭𝐡𝐞𝐲 𝐫𝐞𝐪𝐮𝐢𝐫𝐞 𝐢𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞, 𝐭𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲, 𝐚𝐧𝐝 𝐫𝐞𝐬𝐢𝐥𝐢𝐞𝐧𝐜𝐞. From AI-driven demand forecasting and blockchain-enabled traceability to cloud platforms and advanced analytics, digital transformation is redefining how pharmaceutical supply chains operate end to end. Our latest article outlines 7 proven digital strategies helping pharma leaders strengthen compliance, mitigate risk, improve visibility, and ensure uninterrupted access to critical medicines. 👉 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐨𝐧 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐚𝐧𝐝 𝐬𝐭𝐚𝐲 𝐚𝐡𝐞𝐚𝐝 𝐨𝐟 𝐬𝐮𝐩𝐩𝐥𝐲 𝐜𝐡𝐚𝐢𝐧 𝐝𝐢𝐬𝐫𝐮𝐩𝐭𝐢𝐨𝐧: https://lnkd.in/dqifXKm5 #PharmaSupplyChain #DigitalTransformation #PharmaTechnology #AIinPharma #BlockchainInPharma #SupplyChainTransparency #PharmaOperations #RegulatoryCompliance #PharmaManufacturing #PharmaInnovation

📢 𝐓𝐡𝐞 𝐋𝐚𝐭𝐞𝐬𝐭 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐋𝐢𝐧𝐤𝐞𝐝𝐈𝐧 𝐍𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫 𝐈𝐬 𝐎𝐮𝐭 𝐍𝐨𝐰! Stay ahead in a fast-evolving pharmaceutical landscape with our newest edition—curated for industry leaders, innovators, and decision-makers across the Americas. 🧬 In-depth Articles & Expert Articles 🎙️ Exclusive Interviews with industry voices 📰 Key News & Press Releases 🏗️ Major Projects & Events 📊 Emerging Tech Trends & Research Insights 📄 Insightful White Papers 📘 The Latest Magazine Edition From drug development and manufacturing to digital transformation and regulatory updates, this newsletter delivers the insights that matter—straight to your LinkedIn feed. #PharmaFocusAmerica #PharmaceuticalIndustry #Biopharma #PharmaManufacturing #PharmaTrends #ResearchInsights #WhitePapers #IndustryExperts #PharmaEvents #DigitalHealth #MedicalInnovation

The Philippines is rapidly emerging as a strategic hub for global clinical trials. Join this live webinar featuring IQVIA Philippines, senior leaders from the Department of Health, the Philippines FDA, and top clinical research experts to examine how regulatory alignment, ethics governance, and patient engagement are shaping the country’s clinical research ecosystem. 𝐊𝐞𝐲 𝐝𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧𝐬 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: • FDA alignment with global regulatory standards • PCHRD’s national strategy for clinical research growth • Ethics review processes via PHREN & SJREB • Hospital readiness for multinational trials • Investigator-led patient engagement models 📅 February 4, 2026 | ⏰ 9:30 a.m. ET | ⏳ 60 minutes 👉 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐧𝐨𝐰 𝐚𝐧𝐝 𝐬𝐞𝐜𝐮𝐫𝐞 𝐲𝐨𝐮𝐫 𝐬𝐩𝐨𝐭: https://lnkd.in/gtsJG-BW #ClinicalTrials #PharmaIndustry #IQVIA #RegulatoryAffairs #ClinicalResearch #PatientEngagement #GlobalTrials #PhilippinesHealthcare #Biopharma #LifeSciences #DrugDevelopment #HealthcareInnovation

𝐂𝐚𝐧 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐢𝐧 𝐯𝐢𝐭𝐫𝐨 𝐦𝐨𝐝𝐞𝐥𝐬 𝐦𝐚𝐤𝐞 𝐝𝐫𝐮𝐠 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐬𝐚𝐟𝐞𝐫 𝐚𝐧𝐝 𝐦𝐨𝐫𝐞 𝐩𝐫𝐞𝐝𝐢𝐜𝐭𝐢𝐯𝐞? Traditional in vivo approaches often fail to accurately forecast human outcomes, leading to costly setbacks and ethical challenges. Our white paper explores how next-generation in vitro technologies are reshaping preclinical research. 𝐊𝐞𝐲 𝐥𝐞𝐚𝐫𝐧𝐢𝐧𝐠𝐬: ✔️ Critical differences between in vitro and in vivo models ✔️ Why advanced systems improve safety and efficacy ✔️ Practical strategies for accelerating innovation 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐰𝐡𝐢𝐭𝐞 𝐩𝐚𝐩𝐞𝐫 𝐭𝐨𝐝𝐚𝐲: https://lnkd.in/gQ7Pkvt4 #DrugDevelopment #InVitroModels #LifeSciences